0001104659-24-023650.txt : 20240214 0001104659-24-023650.hdr.sgml : 20240214 20240214161301 ACCESSION NUMBER: 0001104659-24-023650 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240212 FILED AS OF DATE: 20240214 DATE AS OF CHANGE: 20240214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rowe Michael M CENTRAL INDEX KEY: 0001744774 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38365 FILM NUMBER: 24638263 MAIL ADDRESS: STREET 1: C/O EYENOVIA, INC. STREET 2: 501 FIFTH AVENUE, SUITE 1404 CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EYENOVIA, INC. CENTRAL INDEX KEY: 0001682639 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 471178401 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 295 MADISON AVENUE, STREET 2: SUITE 2400 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 813-766-9539 MAIL ADDRESS: STREET 1: 295 MADISON AVENUE, STREET 2: SUITE 2400 CITY: NEW YORK STATE: NY ZIP: 10017 4 1 tm245989-2_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-02-12 0 0001682639 EYENOVIA, INC. EYEN 0001744774 Rowe Michael M C/O EYENOVIA, INC. 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 1 1 0 0 Chief Executive Officer 0 Stock Option (right to buy) 1.91 2024-02-12 4 A 0 75000 0 A 2034-02-12 Common Stock 75000 75000 D One third of the option becomes exercisable on February 12, 2025 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. /s/ Michael Rowe 2024-02-14